Exploring HIV Entry Blockade as a Pre-exposure Prophylaxis Strategy in Women
NCT01749566
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
31
Enrollment
OTHER
Sponsor class
Conditions
HIV
Interventions
DRUG:
maraviroc
Sponsor
Emory University